A detailed history of Planning Capital Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Planning Capital Management Corp holds 1,576 shares of ABT stock, worth $178,718. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,576
Previous 1,576 -0.0%
Holding current value
$178,718
Previous $179 Million 8.58%
% of portfolio
0.12%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$109.52 - $120.96 $38,551 - $42,577
352 Added 28.76%
1,576 $179 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $110,392 - $135,129
1,224 New
1,224 $135 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.